Cargando…
Erratum: Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107049/ https://www.ncbi.nlm.nih.gov/pubmed/37077813 http://dx.doi.org/10.3389/fphar.2023.1188062 |
_version_ | 1785026523637481472 |
---|---|
author | Frontiers Production Office, |
author_facet | Frontiers Production Office, |
author_sort | Frontiers Production Office, |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10107049 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101070492023-04-18 Erratum: Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma Frontiers Production Office, Front Pharmacol Pharmacology Frontiers Media S.A. 2023-04-03 /pmc/articles/PMC10107049/ /pubmed/37077813 http://dx.doi.org/10.3389/fphar.2023.1188062 Text en Copyright © 2023 Frontiers Production Office. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Frontiers Production Office, Erratum: Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma |
title | Erratum: Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma |
title_full | Erratum: Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma |
title_fullStr | Erratum: Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma |
title_full_unstemmed | Erratum: Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma |
title_short | Erratum: Drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma |
title_sort | erratum: drug resistance mechanism of kinase inhibitors in the treatment of hepatocellular carcinoma |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107049/ https://www.ncbi.nlm.nih.gov/pubmed/37077813 http://dx.doi.org/10.3389/fphar.2023.1188062 |
work_keys_str_mv | AT frontiersproductionoffice erratumdrugresistancemechanismofkinaseinhibitorsinthetreatmentofhepatocellularcarcinoma |